Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid. 2021

Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey. Electronic address: ayseoktem@yahoo.com.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010391 Pemphigoid, Bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Pemphigoid,Bullous Pemphigoid,Pemphigoids
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072737 Myeloid-Derived Suppressor Cells A heterogeneous, immature population of myeloid cells that can suppress the activity of T-CELLS and NATURAL KILLER CELLS in the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNE RESPONSE. They play important roles in ONCOGENESIS; INFLAMMATION; and INFECTION. MDSC,Myeloid Derived Suppressor Cell,MDSCs,Cell, Myeloid-Derived Suppressor,Cells, Myeloid-Derived Suppressor,Myeloid Derived Suppressor Cells,Myeloid-Derived Suppressor Cell,Suppressor Cell, Myeloid-Derived,Suppressor Cells, Myeloid-Derived
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
June 2017, BMJ (Clinical research ed.),
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
March 1983, Annals of allergy,
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
January 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
October 1995, The American Journal of dermatopathology,
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
July 2008, BMJ (Clinical research ed.),
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
January 1994, Dermatology (Basel, Switzerland),
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
September 2006, Clinical and experimental dermatology,
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
January 1994, Dermatology (Basel, Switzerland),
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
January 2008, Current directions in autoimmunity,
Ayse Oktem, and Utku Horzum, and Pelin Ertop, and Nihal Kundakci, and Bengu Nisa Akay, and Basak Yalcin, and Gunes Esendagli
January 2016, Clinics in dermatology,
Copied contents to your clipboard!